Baseline serum GDF-15 levels have been found to be an independent predictor of adverse outcomes in COPD patients, including accelerated pulmonary function decline, higher yearly exacerbation rates and increased mortality [28]. The gene discussed is GDF15; the disease is chronic obstructive pulmonary disease.